NCT00005807View on ClinicalTrials.gov

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

BMS-247550

anticancer agent for the treatment of patients with malignant tumors.

Trial Locations (2)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10461

Albert Einstein Clinical Cancer Center, The Bronx

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Albert Einstein College of Medicine

OTHER

NCT00005807 - Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter